Unlike generic medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical to the originator biologic. They are similar, but not the same. Biologics made by different manufacturers differ from the original product and from each other.
More
Biosimilars, also known as follow-on-biologics are “duplicate” and licensed versions of the
Biosimilars, also known as follow-on-biologics are “duplicate” and licensed versions of the biologics that have lost their patent and are
More
With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase
More
Unlike generic medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical
More